LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo targets tough pancreatic tumors
Disease control Recruiting nowThis early-stage study tests a drug called XER-001 given through a tube into the gut, combined with precise radiation, for people with locally advanced pancreatic cancer that cannot be removed by surgery. The main goals are to find the safest dose and see if the treatment can con…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Xerient Pharma • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New radiation pulses aim to tame tough pancreatic tumors
Disease control Recruiting nowThis study tests a new way to deliver radiation called PULSAR, which gives short, powerful pulses of proton therapy every few weeks, adapting to changes in the tumor. It is for people with pancreatic cancer that has not spread widely. The goal is to improve local tumor control wh…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New hope for pancreatic cancer: immune boosting drug combo trial launches
Disease control Recruiting nowThis study tests whether adding two new drugs (zimberelimab and quemliclustat) to standard chemotherapy can help shrink pancreatic tumors that are either borderline removable or have spread locally. The goal is to make surgery possible and improve survival. About 56 adults with u…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
New MRI scan could predict pancreatic cancer treatment success
Diagnosis Recruiting nowThis study tests a special MRI scan that uses an experimental contrast agent called hyperpolarized carbon-13 pyruvate. Unlike standard MRI, this scan shows how tumors process nutrients, which may help doctors predict whether pancreatic cancer treatments are working. The study inv…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Sponsor: University of California, San Francisco • Aim: Diagnosis
Last updated May 26, 2026 05:02 UTC
-
Genetic blueprint may unlock better pancreatic cancer care
Knowledge-focused Recruiting nowThis study looks at whether genetic information from tumors can help doctors choose better treatments for pancreatic cancer. About 200 adults with early or locally advanced pancreatic cancer will give blood, tissue, and fluid samples for genetic testing. Researchers want to see i…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: NA • Sponsor: British Columbia Cancer Agency • Aim: Knowledge-focused
Last updated May 26, 2026 04:36 UTC
-
New study aims to unlock pancreatic Cancer's weaknesses
Knowledge-focused Recruiting nowThis study is for people with pancreatic cancer that can be removed by surgery or has spread. Researchers want to see how different drugs change tumor biology by comparing biopsies taken before and after treatment. The goal is not to cure the disease now, but to learn which drugs…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC
-
New drug OMO-103 studied in pancreatic cancer patients to reveal tumor changes
Knowledge-focused Recruiting nowThis early phase 1 trial is studying how the drug OMO-103 affects pancreatic cancer cells in 12 patients with advanced or metastatic disease. The main goal is to see if the drug causes measurable changes in the tumor's biology by comparing tissue samples taken before and after tr…
Matched conditions: LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Knowledge-focused
Last updated May 18, 2026 12:10 UTC